Administration of Extended Infusion Piperacillin-TazobactamWith the Use of Smart Pump Technology (Q33774704)

29 July 2017

title

Administration of Extended Infusion Piperacillin-TazobactamWith the Use of Smart Pump Technology (English)

1 reference

29 July 2017

Megan L Maddox

1

1 reference

29 July 2017

Erica C DeBoer

series ordinal

2

1 reference

29 July 2017

Rhonda J Hammerquist

series ordinal

3

1 reference

29 July 2017

language of work or name

1 reference

1 May 2014

1 reference

29 July 2017

1 reference

29 July 2017

volume

49

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

444-448

1 reference

Prolonged infusion antibiotics for suspected gram-negative infections in the ICU: a before-after study

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062718

Population pharmacokinetics of extended-infusion piperacillin-tazobactam in hospitalized patients with nosocomial infections

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062718

The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) study: a multicenter study.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062718

In vivo pharmacodynamic profiling of doripenem against Pseudomonas aeruginosa by simulating human exposures

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062718

Setting and revising antibacterial susceptibility breakpoints

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062718

Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062718

Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062718

Antimicrobial stewardship programs in health care systems

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062718

Use of pharmacokinetic-pharmacodynamic target attainment analyses to support phase 2 and 3 dosing strategies for doripenem

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062718

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062718

Pharmacokinetics, safety, and tolerability of doripenem after 0.5-, 1-, and 4-hour infusions in healthy volunteers.

4 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1310%2FHPJ4905-444

Pharmacodynamic target attainment of six beta-lactams and two fluoroquinolones against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and Klebsiella species collected from United States intensive care units in 2004.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1310%2FHPJ4905-444

Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1310%2FHPJ4905-444

Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062718

Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24958956

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1310/HPJ4905-444

1 reference

29 July 2017

1 reference

29 July 2017

1 reference